Jens Koopmann
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
-
- Bone and Dental Protein Studies 3
-
- Epigenetics and DNA Methylation 1
- Co-authors
- Michael Goggins (8 shared papers)Charles J. Yeo (6 shared papers)Ralph H. Hruban (6 shared papers)Otmar D. Wiestler (3 shared papers)David N. Louis (3 shared papers)Andreas von Deimling (3 shared papers)David Maintz (3 shared papers)Noriyoshi Fukushima (3 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Journal of Neuropathology & Experimental Neurology (2 papers)Modern Pathology (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Jens Koopmann
15 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 79
- Genetics 521
- Cancer Research 400
- Rheumatology 387
- Oncology 554
- Spectroscopy 175
Countries citing papers authored by Jens Koopmann
This map shows the geographic impact of Jens Koopmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Koopmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Koopmann more than expected).
Fields of papers citing papers by Jens Koopmann
This network shows the impact of papers produced by Jens Koopmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Koopmann. The network helps show where Jens Koopmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Jens Koopmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 298 | |
| 2 | 2003 | 232 | |
| 3 | 2004 | 226 | |
| 4 | 2004 | 225 | |
| 5 | 1997 | 203 | |
| 6 | 2006 | 167 | |
| 7 | 2004 | 158 | |
| 8 | Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. | 1996 | 156 |
| 9 | 2004 | 84 | |
| 10 | 2005 | 59 | |
| 11 | 2018 | 37 | |
| 12 | 2004 | 32 | |
| 13 | 1994 | 15 | |
| 14 | 2003 | 15 | |
| 15 | 2010 | 1 |
About Jens Koopmann
Jens Koopmann is a scholar working on Rheumatology, Molecular Biology, Oncology, Surgery and Genetics, having authored 15 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bone and Dental Protein Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer-related molecular mechanisms research (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Advanced Proteomics Techniques and Applications (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Genetics (521 citations), Cancer Research (400 citations), Rheumatology (387 citations), Oncology (554 citations) and Spectroscopy (175 citations). Jens Koopmann has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Michael Goggins, Charles J. Yeo, Ralph H. Hruban, Otmar D. Wiestler, David N. Louis, Andreas von Deimling, David Maintz, Noriyoshi Fukushima, Norihiro Sato and Johannes Schramm. Their work appears in journals such as Clinical Cancer Research, Journal of Neuropathology & Experimental Neurology, Modern Pathology, Cancer Epidemiology Biomarkers & Prevention and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.